Dr. Anusha Kalbasi is a radiation oncologist and translational scientist in the UCLA Department of Radiation Oncology and Division of Cellular and Molecular Oncology. As part of the Ribas Lab in the Parker Institute for Cancer Immunotherapy, his research is focused on immunotherapeutic strategies for the treatment of solid malignancies.
Dr. Kalbasi specializes in the treatment of sarcoma and melanoma. He has a broad clinical background, and has published on pancreatic, lung, prostate, melanoma, and hepatobiliary cancers. He is experienced in advanced treatment approaches, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), image-guided radiotherapy, and proton therapy.
Dr. Kalbasi earned his undergraduate degree UCLA with highest honors (summa cum laude) and graduated with honors (AOA) from the David Geffen School of Medicine at UCLA. During medical school, he completed an HHMI-NIH research fellowship at the National Cancer Institute, where he worked on genetically engineering T cells for the treatment of solid tumors. Dr. Kalbasi completed his residency in radiation oncology at the University of Pennsylvania, where he completed a research fellowship in pancreatic cancer immunotherapy. He was granted a Conquer Cancer Foundation of ASCO Young Investigator Award for his work on understanding the role of macrophages in resistance to radiation therapy.